A dual altered peptide ligand down-regulates myasthenogenicT cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis - Aruna, BV; Ben David, H; Sela, M; Mozes, E (Immunology, 2006)